DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease and related conditions. Together, we believe we can transform the future of patient care for the better.
Our Strategy
We aim to invest in, acquire, and co-develop products, solutions and businesses that improve care for patients with kidney disease and related conditions.
Priorities
- Care Delivery Models: Advancements to expand access to care and improve clinical outcomes through adoption of tech-enabled services, home treatments and value-based care
- Life Sciences: Pharmaceuticals, medical devices and diagnostics that can improve clinical outcomes and patient experience while reducing costs
- Digital Health: Products and services that leverage technology, data and connectivity to improve care delivery